enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2026)

enVVeno Medical has reported Cash from Investing Activities for 10 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 46.74% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (up 209.47% YoY), and the FY2025 full-year result was $15.9 million, up 1087.72% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $2.8 million, down from $4.2 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $7.0 million in Q2 2023, with the low at -$38.3 million in Q2 2022.
• Average Cash from Investing Activities over 5 years is -$1.3 million, with a median of $2.8 million recorded in 2023.
• Peak annual rise in Cash from Investing Activities reached 8586.15% in 2022, while the deepest fall reached 30064.57% in 2022.
• Tracing NVNO's Cash from Investing Activities over 5 years: stood at $5.5 million in 2022, then slumped by 501.45% to -$22.1 million in 2023, then surged by 50.07% to -$11.1 million in 2024, then surged by 137.83% to $4.2 million in 2025, then slumped by 33.76% to $2.8 million in 2026.
• The last three Cash from Investing Activities figures came in at $2.8 million (Q1 2026), $4.2 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.

Peer Comparison